Tag: stenosis
AVeNEW trial shows superior AVF target lesion patency with covered stent...
“Study design is critically important when interpreting outcomes,” said Bart Dolmatch (Mountain View Hospital, Mountain View, USA) in his evaluation of the “disconnect” between...
Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace...
Robert Shahverdyan (Hamburg, Germany) encourages interventionalists to try the new Flex Vessel Prep system (VentureMed) to experience the benefits that arrive in the wake...
Dynamic AVFs: A promising solution in the making
Koen van der Bogt is a vascular surgeon at Haaglanden Medical Centre (The Hague, The Netherlands) and Leiden University Medical Centre (Leiden, The Netherlands)....
Enrolment completed in SAVE trial of Selution SLR for AVF treatment
MedAlliance has announced completion of patient enrolment in the SAVE clinical trial with the Selution Sustained Limus Release (SLR) 018 drug-eluting balloon (DEB) for...
DCB superior to plain balloon for stent graft stenosis in Taiwanese...
Recent studies have evaluated drug-coated balloon (DCB) treatments’ ability to help maintain arteriovenous fistula (AVF) patency for haemodialysis patients “with mixed results”, according to...
Daniel Patel
American Society of Diagnostic and Interventional Nephrology (ASDIN) certification and accreditation chairman Daniel Patel is the medical director for interventional nephrology at the Volusia-Flagler...
PAVE-2, paclitaxel and sirolimus-coated balloons for AVF
Michael Robson and Narayan Karunanithy (King’s College London, London, UK) write to explore the range of options in drug-coated balloons (DCBs) for stenosis in...
Vasc-Alert shares new data endorsing its vascular access blockage prediction technology
Vasc-Alert, a pioneer in vascular access surveillance, has announced the publication of a study in the Journal of Vascular Access (JVA) validating its Vasc-Alert...
Transit Scientific announces US FDA clearance for XO RX angioplasty platform
Transit Scientific has announced that the XO RX 2.2Fr and XO RX 3.8Fr platform has received US Food and Drug Administration (FDA) clearance to...
First patient enrolled in Merit Medical’s WRAPSODY registry study
Merit Medical has announced the successful enrolment of the first patient in its WRAP registry study in a press release. This study will evaluate...
Plain balloon first and drug-eluting balloon second? The role of DCBs...
Kate Steiner (Stevenage, UK) discusses existing clinical evidence on drug-coated balloons (DCBs) in the treatment of arteriovenous access stenosis—and outlines areas where further data...
PatenSee’s contactless imaging device demonstrates promise in timely and accurate monitoring...
The interim results of an ongoing clinical study of PatenSee's contactless imaging device for the early detection of vascular access stenosis in dialysis patients...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...